800-331-6634

One in four anti-VEGF therapy patients with DME lost to follow-up

By http://www.midatlanticretina.com/author
January 18, 2019

Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.

 

Category:


Comments are closed.